Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)

Summary

A randomized, controlled study of standard soy milk consumption compared to 2% fat cow's milk consumption in children with Non-alcoholic Fatty Liver Disease (NAFLD). The investigators hypothesize that the daily consumption of soy isoflavones found in the soy milk will be beneficial in reducing NAFLD and other obesity-related comorbidities. The investigators do not expect any adverse endocrine or metabolomic effects from the consumption of soy isoflavones.

Eligibility

Age range

5–16 years

Sex

All

Healthy volunteers

No

Interventions

• Drug
  Standard Soy Milk

  Consumption of commercially available soy milk

• Drug
  2% Fat Cow's Milk

  Consumption of commercially available 2% cow's milk

Location